Literature DB >> 6229073

Induction of antibodies by blood transfusions capable of inhibiting responses in MLC.

P S Nagarkatti, S Joseph, D P Singal.   

Abstract

B6AF1 (H-2KbkDbd) mice were transfused weekly with 0.1 ml of whole blood from DBA/2 (H-2d) mice. One week after each transfusion, the mice were bled and the sera were collected and pooled. The presence of antiidiotypic antibodies in these sera was investigated using the mixed-lymphocyte culture (MLC) inhibition test, in which spleen cells from normal B6AF1 mice were treated with sera from transfused B6AF1 mice, washed, and then tested for their responses to DBA/2 stimulator cells. The sera collected following 3 and 4 transfusions caused a significant inhibition of responses in MLC, but sera obtained after 1 and 2 transfusions caused little or no inhibition. This inhibition was specific for stimulator cells from the blood donor (DBA/2) and was not observed against third-party SJL (H-2s) stimulator cells. In addition, the suppressive effect in MLC was specific for responder cells from the recipient B6AF1 mice, and no suppression was observed with responder cells from C3H (H-2k) and SJL mice. Treatment of DBA/2 stimulator cells with the serum caused no inhibition in MLC. The MLC inhibitory activity of the serum decreased gradually from the first to the third week following 4 transfusions, although a significant inhibition was still demonstrable after 3 weeks. These findings suggest that multiple blood transfusions induce antiidiotypic antibodies that can block the T cell antigen-specific receptors and cause suppression of the recipient's responses against the donor's alloantigens in MLC.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6229073     DOI: 10.1097/00007890-198336060-00022

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Allogeneic suppressive effects of pregnancy sera on monocytes of responding cells in human mixed lymphocyte reactions.

Authors:  M Nieda; T Juji; S Imao
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

2.  Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies.

Authors:  D P Singal; M A Blajchman; S Joseph; B Roberge; E K Smith; D Ludwin
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

3.  Role of MLC serum inhibitory factors in high MLC-reactive kidney transplant recipients pretreated with donor-specific blood transfusion (DST).

Authors:  K Sakagami; H Takeuchi; T Matsumoto; K Tsuboi; H Ohsaki; K Tanaka; K Ohiwa; K Orita
Journal:  Jpn J Surg       Date:  1986-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.